215 related articles for article (PubMed ID: 35015108)
1. [Hepatitis B vaccines-history, achievements, challenges, and perspectives].
Gerlich WH
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Feb; 65(2):170-182. PubMed ID: 35015108
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.
Gerlich WH
Med Microbiol Immunol; 2015 Feb; 204(1):39-55. PubMed ID: 25523195
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana.
Baruti K; Lentz K; Anderson M; Ajibola G; Phinius BB; Choga WT; Mbangiwa T; Powis KM; Sebunya T; Blackard JT; Lockman S; Moyo S; Shapiro R; Gaseitsiwe S
PLoS One; 2020; 15(8):e0237252. PubMed ID: 32764801
[TBL] [Abstract][Full Text] [Related]
5. [Neutralization of hepatitis B virus with vaccine-escape mutations by novel hepatitis B vaccine with large-HBs antigen].
Kato T; Akari H
Uirusu; 2023; 72(2):149-158. PubMed ID: 38220203
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates.
Vranckx R; Alisjahbana A; Meheus A
J Viral Hepat; 1999 Mar; 6(2):135-9. PubMed ID: 10607224
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic vaccine-induced plasma cell differentiation is defective in the presence of persistently high HBsAg levels.
Qi R; Fu R; Lei X; He J; Jiang Y; Zhang L; Wu Y; Wang S; Guo X; Chen F; Nie M; Yang M; Chen Y; Zeng J; Xu J; Xiong H; Fang M; Que Y; Yao Y; Wang Y; Cao J; Ye H; Zhang Y; Zheng Z; Cheng T; Zhang J; Lin X; Yuan Q; Zhang T; Xia N
J Hepatol; 2024 May; 80(5):714-729. PubMed ID: 38336348
[TBL] [Abstract][Full Text] [Related]
9. A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice.
Zhang TY; Guo XR; Wu YT; Kang XZ; Zheng QB; Qi RY; Chen BB; Lan Y; Wei M; Wang SJ; Xiong HL; Cao JL; Zhang BH; Qiao XY; Huang XF; Wang YB; Fang MJ; Zhang YL; Cheng T; Chen YX; Zhao QJ; Li SW; Ge SX; Chen PJ; Zhang J; Yuan Q; Xia NS
Gut; 2020 Feb; 69(2):343-354. PubMed ID: 30926653
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen.
Washizaki A; Murayama A; Murata M; Kiyohara T; Yato K; Yamada N; Aly HH; Tanaka T; Moriishi K; Nishitsuji H; Shimotohno K; Goh Y; Ishii KJ; Yotsuyanagi H; Muramatsu M; Ishii K; Takahashi Y; Suzuki R; Akari H; Kato T
Nat Commun; 2022 Sep; 13(1):5207. PubMed ID: 36064848
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B vaccination.
Romanò L; Paladini S; Galli C; Raimondo G; Pollicino T; Zanetti AR
Hum Vaccin Immunother; 2015; 11(1):53-7. PubMed ID: 25483515
[TBL] [Abstract][Full Text] [Related]
12. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
Cooreman MP; Leroux-Roels G; Paulij WP
J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
[TBL] [Abstract][Full Text] [Related]
13. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C
Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363
[TBL] [Abstract][Full Text] [Related]
14. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM
J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008
[TBL] [Abstract][Full Text] [Related]
15. PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response.
Petit MA; Capel F; Zoulim F; Dubanchet S; Chemin I; Penna A; Ferrari C; Trépo C
Arch Virol Suppl; 1992; 4():105-12. PubMed ID: 1280500
[TBL] [Abstract][Full Text] [Related]
16. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
Krawczyk A; Ludwig C; Jochum C; Fiedler M; Heinemann FM; Shouval D; Roggendorf M; Roggendorf H; Lindemann M
Vaccine; 2014 Sep; 32(39):5077-82. PubMed ID: 24975813
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.
Chang YC; Wang JH; Chen YS; Lin JS; Cheng CF; Chu CH
BMC Public Health; 2014 Sep; 14():991. PubMed ID: 25248369
[TBL] [Abstract][Full Text] [Related]
18. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
[TBL] [Abstract][Full Text] [Related]
19. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.
Kuhns MC; McNamara AL; Holzmayer V; Cloherty GA
Virol J; 2019 Apr; 16(1):43. PubMed ID: 30943997
[TBL] [Abstract][Full Text] [Related]
20. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
